146 related articles for article (PubMed ID: 20210784)
21. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
Leroux C; Issel CJ; Montelaro RC
J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
[TBL] [Abstract][Full Text] [Related]
22. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.
Alexandersen S; Carpenter S
J Virol; 1991 Aug; 65(8):4255-62. PubMed ID: 1649329
[TBL] [Abstract][Full Text] [Related]
23. Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.
Sparks WO; Dorman KS; Liu S; Carpenter S
J Gen Virol; 2008 Apr; 89(Pt 4):1043-1048. PubMed ID: 18343848
[TBL] [Abstract][Full Text] [Related]
24. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.
Wang XF; Wang YH; Bai B; Zhang M; Chen J; Zhang X; Gao M; Wang X
J Virol; 2021 Nov; 95(23):e0108721. PubMed ID: 34495693
[TBL] [Abstract][Full Text] [Related]
25. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
[TBL] [Abstract][Full Text] [Related]
26. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
[TBL] [Abstract][Full Text] [Related]
27. Structural model of the Rev regulatory protein from equine infectious anemia virus.
Ihm Y; Sparks WO; Lee JH; Cao H; Carpenter S; Wang CZ; Ho KM; Dobbs D
PLoS One; 2009; 4(1):e4178. PubMed ID: 19137065
[TBL] [Abstract][Full Text] [Related]
28. Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.
Baccam P; Thompson RJ; Li Y; Sparks WO; Belshan M; Dorman KS; Wannemuehler Y; Oaks JL; Cornette JL; Carpenter S
J Virol; 2003 Nov; 77(22):12122-31. PubMed ID: 14581549
[TBL] [Abstract][Full Text] [Related]
29. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.
Craigo JK; Barnes S; Zhang B; Cook SJ; Howe L; Issel CJ; Montelaro RC
Retrovirology; 2009 Oct; 6():95. PubMed ID: 19843328
[TBL] [Abstract][Full Text] [Related]
30. Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity.
Tang YD; Na L; Fu LH; Yang F; Zhu CH; Tang L; Li Q; Wang JY; Li Z; Wang XF; Li CY; Wang X; Zhou JH
Virology; 2015 Feb; 476():364-371. PubMed ID: 25589239
[TBL] [Abstract][Full Text] [Related]
31. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of CpG islands in equine infectious anemia virus strains.
Liu Q; Yu YY; Wang HY
Virus Genes; 2020 Jun; 56(3):339-346. PubMed ID: 32239368
[TBL] [Abstract][Full Text] [Related]
33. Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.
Mancuso VA; Hope TJ; Zhu L; Derse D; Phillips T; Parslow TG
J Virol; 1994 Mar; 68(3):1998-2001. PubMed ID: 8107262
[TBL] [Abstract][Full Text] [Related]
34. Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element.
Otero GC; Harris ME; Donello JE; Hope TJ
J Virol; 1998 Sep; 72(9):7593-7. PubMed ID: 9696859
[TBL] [Abstract][Full Text] [Related]
35. General effect of Sam68 on Rev/Rex regulated expression of complex retroviruses.
Reddy TR; Xu WD; Wong-Staal F
Oncogene; 2000 Aug; 19(35):4071-4. PubMed ID: 10962565
[TBL] [Abstract][Full Text] [Related]
36. Serologically silent, occult equine infectious anemia virus (EIAV) infections in horses.
Ricotti S; Garcia MI; Veaute C; Bailat A; Lucca E; Cook RF; Cook SJ; Soutullo A
Vet Microbiol; 2016 May; 187():41-49. PubMed ID: 27066707
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.
Tan W; Schalling M; Zhao C; Luukkonen M; Nilsson M; Fenyö EM; Pavlakis GN; Schwartz S
J Virol; 1996 Jun; 70(6):3645-58. PubMed ID: 8648699
[TBL] [Abstract][Full Text] [Related]
38. Regulation of equine infectious anemia virus expression.
Maury W
J Biomed Sci; 1998; 5(1):11-23. PubMed ID: 9570509
[TBL] [Abstract][Full Text] [Related]
39. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.
Li F; Leroux C; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
J Virol; 2000 Jan; 74(1):573-9. PubMed ID: 10590152
[TBL] [Abstract][Full Text] [Related]
40. EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy.
Craigo JK; Montelaro RC
Curr HIV Res; 2010 Jan; 8(1):81-6. PubMed ID: 20210783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
